SeaSpine has announced the full commercial launch of its Hollywood VI NanoMetalene transforaminal lumbar interbody fusion device.
Hollywood VI NanoMetalene is indicated for use in spinal fusion procedures at one or two contiguous levels (L2-S1) in skeletally mature patients with degenerative disc disease. It is the most recent device to use SeaSpine’s NanoMetalene technology—others being the Hollywood NanoMetalene, Ventura NanoMetalene and cervical Cambria NanoMetalene interbody devices.
NanoMetalene is a sub-micron layer of commercially pure titanium molecularly bonded to a PEEK-Optima polymer from Invibio. It is applied in a proprietary high-energy, low-temperature surface process, which is designed to allow for titanium nano topography to encompass the entire implant. The NanoMetalene coating is intended to provide the surface benefits of titanium while retaining the benefits associated with traditional PEEK-Optima devices such as biocompatibility, modulus of elasticity similar to bone, and radiographic visibility for post-op imaging.
With a curved, anatomically geometric shape, the Hollywood VI NanoMetalene implant designed for placement in the anterior column of the spine.
This variable insertion (VI) design is intended to facilitate final implant placement within the disc space, and to provide TLIF surgeons options tailored for their patients. Hollywood VI NanoMetalene also has a completely coated graft aperture for autogenous bone graft for fusion.
SeaSpine expects to launch additional NanoMetalene coated PEEK interbody devices in future periods.